AN2 Therapeutics, Inc.
USD4.07
-0.14 (-3.33%)
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.39
Prev. Close
$4.21
Day Low
$4.04
Day High
$4.46
52W Low
$1.00
52W High
$6.91
Market Cap
$0.11B
Volume
0.18M
| 3,775 |
| $0.00 |
| 10 Apr 2026 | Martin Patricia A. | director | A-Award | Acquired | 1,192 | $0.00 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 73,665 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 73,665 | $6.60 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 66,000 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 66,000 | $17.28 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 82,300 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 82,300 | $14.29 |
| 23 Mar 2026 | Chanda Sanjay | Chief Development Officer | A-Award | Acquired | 66,000 | $3.91 |